155 related articles for article (PubMed ID: 30881820)
1. Immunohistochemical Expression of Cyclooxygenases in Hypertrophic Scars and Keloids.
Pavelecini M; Zettler CG; Fernandes MC; Ely PB
Plast Reconstr Surg Glob Open; 2019 Feb; 7(2):e2030. PubMed ID: 30881820
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic and keloid scars fail to progress from the CD34
Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
4. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
[TBL] [Abstract][Full Text] [Related]
5. Increased epidermal thickness and abnormal epidermal differentiation in keloid scars.
Limandjaja GC; van den Broek LJ; Waaijman T; van Veen HA; Everts V; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2017 Jan; 176(1):116-126. PubMed ID: 27377288
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of COX-1 and COX-2 expression in keloid and hypertrophic scar.
Abdou AG; Maraee AH; Saif HF
Am J Dermatopathol; 2014 Apr; 36(4):311-7. PubMed ID: 24061401
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Fractional CO
Tawfic SO; El-Tawdy A; Shalaby S; Foad A; Shaker O; Sayed SS; Metwally D
Lasers Surg Med; 2020 Dec; 52(10):959-965. PubMed ID: 32293045
[TBL] [Abstract][Full Text] [Related]
8. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of actin and myosin in the scar tissue].
Zhang Q; Qian YL; Cui L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
Seleit I; Bakry OA; Samaka RM; Tawfik AS
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
[TBL] [Abstract][Full Text] [Related]
11. [A study of the abnormalities of human epiderm in keloids and hypertrophic scars].
He XJ; Han CM; Peng JP
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(14):845-8. PubMed ID: 15363271
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Role of Granzyme B in Exuberant Scar Pathogenesis: An Immunohistochemical Study.
Bakry OA; Younes SF; Abdel Wahed M; El Farargy SM; Sharawy S
Anal Quant Cytopathol Histpathol; 2015 Aug; 37(4):221-6. PubMed ID: 26410968
[TBL] [Abstract][Full Text] [Related]
13. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
[TBL] [Abstract][Full Text] [Related]
14. THE USAGE OF RADIOFREQUENCY ABLATION FOR TREATMENT OF KELOIDS AND HYPERTROPHIC SCARS.
Teplyi V; Grebchenko K
Probl Radiac Med Radiobiol; 2019 Dec; 24():561-573. PubMed ID: 31841496
[TBL] [Abstract][Full Text] [Related]
15. [Variations of lipid peroxidation products and copper, zinc-superoxide dismutase in pathological scars].
Li W; Cen Y; Wang H; Chen W; Liu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):838-41. PubMed ID: 18681286
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Transforming Growth Factor β1, Platelet-Derived Growth Factor, and Basic Fibroblast Growth Factor by Silicone Gel Sheeting in Early-Stage Scarring.
Choi J; Lee EH; Park SW; Chang H
Arch Plast Surg; 2015 Jan; 42(1):20-7. PubMed ID: 25606485
[TBL] [Abstract][Full Text] [Related]
18. Nd:YAG Laser Treatment for Keloids and Hypertrophic Scars: An Analysis of 102 Cases.
Koike S; Akaishi S; Nagashima Y; Dohi T; Hyakusoku H; Ogawa R
Plast Reconstr Surg Glob Open; 2014 Dec; 2(12):e272. PubMed ID: 25587506
[TBL] [Abstract][Full Text] [Related]
19. Review of Silicone Gel Sheeting and Silicone Gel for the Prevention of Hypertrophic Scars and Keloids.
Hsu KC; Luan CW; Tsai YW
Wounds; 2017 May; 29(5):154-158. PubMed ID: 28570253
[TBL] [Abstract][Full Text] [Related]
20. Nd:YAG Laser Treatment of Keloids and Hypertrophic Scars.
Akaishi S; Koike S; Dohi T; Kobe K; Hyakusoku H; Ogawa R
Eplasty; 2012; 12():e1. PubMed ID: 22259645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
